Breast Cancer Survivors RESET (Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools): A Pilot, Feasibility Study
NCT ID: NCT07101861
Last Updated: 2025-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
37 participants
INTERVENTIONAL
2024-01-20
2026-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
BCRL Prevention Pilot
NCT01166672
Intervention to Improve the Delivery of Follow-up Care for Low-Risk Breast Cancer
NCT05609435
Breast Cancer Resiliency Through Exercise Program (B-REP)
NCT06100263
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
NCT07214610
High Physical Activity During a Weight Loss Intervention for Breast Cancer Survivors and High Risk Women
NCT03270111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SEQUENTIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Survivors RESET intervention
Survivors RESET
16-session adaptation of the Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survivors RESET
16-session adaptation of the Diabetes Prevention Program Intensive Lifestyle Intervention plus stress management training
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identify as cisgendered female.
* Are ≥ age 18.
* Have a history of stage 0-3 breast cancer diagnosis treated for curative intent.
* Have completed all adjuvant or neoadjuvant chemotherapy, radiation, and surgery at least 21 days prior to study registration but may continue on hormonal therapy and Abemaciclib therapy.
* Have a measured BMI ≥ 30 kg/m2.
* Willing to participate for the entire 4-month duration.
Exclusion Criteria
* Have a known major medical or psychological condition known to influence weight loss \[e.g., medicated or poorly controlled diabetes (HbA1c \> 8%), uncontrolled hypertension (BP\>160 mm Hg systolic or BP\>100 mm Hg diastolic), cardiovascular event in the past 12 months, history of gastric bypass or bariatric surgery\].
* History of psychiatric hospitalization in past 2 years.
* History of substance abuse or eating disorder.
* Any other condition by which a medical professional has suggested diet modification, physical activity, and/or weight loss would be contraindicated.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
H. Lee Moffitt Cancer Center and Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tiffany Carson, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Moffitt Cancer Center
Tampa, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MCC-22616
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.